1. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives
   Marisa Coelho et al, 2017, J Cancer Res Clin Oncol CrossRef
2. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study
   Mario Iannaccone et al, 2017, Am J Cardiovasc Drugs CrossRef
3. B2 adrenergic receptors and morphological changes of the enteric nervous system in colorectal adenocarcinoma
   Raluca Niculina Ciurea et al, 2017, WJG CrossRef
4. Neuroendocrine factors: The missing link in non‑melanoma skin cancer (Review).
   Nikolaos Drakoulis, 0 CrossRef
5. Activation of β-adrenergic receptor promotes cellular proliferation in human glioblastoma.
   Jing-Jing He et al, 2017, Oncol Lett CrossRef
6. Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process
   Corina Behrenbruch et al, 2018, Clin Exp Metastasis CrossRef
7. Can Stopping Nerves, Stop Cancer?
   Jami L. Saloman et al, 2016, Trends in Neurosciences CrossRef
8. β2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
   Christopher T. Lucido et al, 2018, Oncogenesis CrossRef
9. Selective β2-adrenoreceptor signaling regulates osteoclastogenesis via modulating RANKL production and neuropeptides expression in osteocytic MLO-Y4 cells
   Hengxing Liang et al, 2018, J Cell Biochem CrossRef
10. Propranolol Promotes Glucose Dependence and Synergizes with Dichloroacetate for Anti-Cancer Activity in HNSCC
    Christopher Lucido et al, 2018, Cancers CrossRef
11. A direct effect of the autonomic nervous system on somatic stem cell proliferation?
    Elizabeth A. Davis et al, 2019, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology CrossRef
12. Propranolol selectively inhibits cervical cancer cell growth by suppressing the cGMP/PKG pathway
    Liuyun Gong et al, 2019, Biomedicine & Pharmacotherapy CrossRef
13. Is preoperative chemoradiation in rectal cancer patients modulated by ACE inhibitors? Results from the Dutch Cancer Registry
    Anouk J. Rombouts et al, 2019, Radiotherapy and Oncology CrossRef
14. Role of the brain-gut axis in gastrointestinal cancer
    Yang-Zi Di et al, 2019, WJCC CrossRef
15. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease
    A. M. Cuesta et al, 2019, Sci Rep CrossRef
16. Differential Free Intracellular Calcium Release by Class II Antiarrhythmics in Cancer Cell Lines
    Marta Reyes-Corral et al, 2019, J Pharmacol Exp Ther CrossRef
17. Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System
    Imogen M. Roth et al, 2019, Front. Oncol. CrossRef
18. Esmolol attenuates lung injury and inflammation in severe acute pancreatitis rats
    Luyao Zhang et al, 2016, Pancreatology CrossRef
19. Effects of Intraoperative Infusion of Esmolol on Systemic and Pulmonary Inflammation in a Porcine Experimental Model of Lung Resection Surgery
    Ignacio Garutti et al, 2019, Anesthesia & Analgesia CrossRef
20. The adrenergic receptor antagonists propranolol and carvedilol decrease bone sarcoma cell viability and sustained carvedilol reduces clonogenic survival and increases radiosensitivity in canine osteosarcoma cells
    Megan M. Duckett et al, 2019, Vet Comp Oncol CrossRef
21. Norepinephrine-CREB1-miR-373 axis promotes progression of colon cancer.
    Jia Han et al, 2020, Mol Oncol CrossRef
22. Intra-operative norepinephrine administration and cancer-related outcomes following radical cystectomy for bladder cancer
    Lukas M. Löffel et al, 2020, European Journal of Anaesthesiology CrossRef
23. β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma
    George Zaki Ghali et al, 2020, Mol Biol Rep CrossRef
24. Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0/G1/S phase arrest in malignant melanoma
    Xinwei Kuang et al, 2018, Oncotarget CrossRef
25. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer
    Alexa Montoya et al, 2017, Oncotarget CrossRef
26. Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway
    Chengfang Zhou et al, 2016, Oncotarget CrossRef
27. Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins
    Raimundo De Ara�jo Jr et al, 2017, Int J Oncol CrossRef
28. Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing
    Riccardo Giampieri et al, 2020, Cancers CrossRef
29. β-Adrenoceptor Activation in Breast MCF-10A Cells Induces a Pattern of Catecholamine Production Similar to that of Tumorigenic MCF-7 Cells
    Filipa Amaro et al, 2020, IJMS CrossRef
30. Neurobiology of Cancer: the Role of β-Adrenergic Receptor Signaling in Various Tumor Environments.
    Boris Mravec et al, 2020, Int J Mol Sci CrossRef
31. Impairment of Hypoxia-Induced CA IX by Beta-Blocker Propranolol—Impact on Progression and Metastatic Potential of Colorectal Cancer Cells
    Monika Barathova et al, 2020, IJMS CrossRef
32. Gene Expression Integration into Pathway Modules Reveals a Pan-Cancer Metabolic Landscape
    Cankut Cubuk et al, 2018, Cancer Res CrossRef
33. Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis
    Masahiro Koh et al, 2021, Gastric Cancer CrossRef
34. Unveiling the Pathogenesis of Perineural Invasion from the Perspective of Neuroactive molecules
    Michelle Melgarejo da Rosa et al, 2021, Biochemical Pharmacology CrossRef
35. Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps
    Celina N. Santiago et al, 2021, Cancer Prev Res CrossRef
36. Regulation of the Autonomic Nervous System on Intestine
    Hongyi Duan et al, 2021, Front. Physiol. CrossRef
37. Colon adenocarcinoma-derived cells possessing stem cell function can be modulated using renin-angiotensin system inhibitors
    Matthew J. Munro et al, 2021, PLoS ONE CrossRef
38. Cancer catecholamine conundrum
    H. Wackerhage et al, 2021, Trends in Cancer CrossRef
39. Propranolol Inhibits the Growth of Cervical Cancer Cells by Inhibiting Cyclic Guanosine Monophosphate/Protein Kinase G (cGMP/PKG) Pathway
    Mi Li et al, 2022, j biomater tissue eng CrossRef
40. Nerve Dependence in Colorectal Cancer
    Lincheng Zhang et al, 2022, Front. Cell Dev. Biol. CrossRef
41. Cross‐talk of cholinergic and β‐adrenergic receptor signalling in chronic myeloid leukemia K562 cells
    Banu Aydın et al, 2022, Clin Exp Pharma Physio CrossRef
42. Beta adrenergic blockade and clinical outcomes in patients with colorectal cancer: A systematic review and meta-analysis
    Junwei Wang et al, 2022, European Journal of Pharmacology CrossRef
43. Anticancer potential of yohimbine in drug-resistant oral cancer KB-ChR-8–5 cells
    Nasimudeen R. Jabir et al, 2022, Mol Biol Rep CrossRef
44. Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy
    Luisina M. Solernó et al, 2022, Sci Rep CrossRef
45. Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases
    Natalia S. Pellegata et al, 2022, Cancer Metastasis Rev CrossRef
46. A literature perspective on the pharmacological applications of yohimbine
    Nasimudeen R. Jabir et al, 2022, Annals of Medicine CrossRef
47. Targeting the β 2 ‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
    Hatice Satilmis et al, 2023, The Journal of Pathology CrossRef
48. Behavioral factors to modulate immunotherapy efficacy in cancer
    C. Jongerius et al, 2022, Front. Immunol. CrossRef
49. null
    Debanjan Chakroborty et al, 2022 CrossRef
50. Perioperative escape from dormancy of spontaneous micro-metastases: A role for malignant secretion of IL-6, IL-8, and VEGF, through adrenergic and prostaglandin signaling
    Rita Haldar et al, 2023, Brain, Behavior, and Immunity CrossRef
51. null
    Sabrina P. Koh et al, 2023 CrossRef
52. Camphor and Menthol as Anticancer Agents: Synthesis, Structure-Activity Relationship and Interaction with Cancer Cell Lines
    Himanshu Singh et al, 2023, ACAMC CrossRef
53. Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer
    Yanting Lin et al, 2023, European Journal of Pharmacology CrossRef
54. In Vitro and In Silico Study on the effect of Carvedilol and Sorafenib Alone and in Combination on the Growth and Inflammatory Response of Melanoma Cells
    Joanna Wawszczyk et al, 2023, Saudi Pharmaceutical Journal CrossRef
55. Trial watch: beta-blockers in cancer therapy
    Killian Carnet Le Provost et al, 2023, OncoImmunology CrossRef
56. Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
    Rachel Massalee et al, 2024, Front. Pharmacol. CrossRef
57. Design of a Remote Time-Restricted Eating and Mindfulness Intervention to Reduce Risk Factors Associated with Early-Onset Colorectal Cancer Development among Young Adults
    Manoela Lima Oliveira et al, 2024, Nutrients CrossRef
58. G protein‐coupled receptor‐mediated autophagy in health and disease
    Devrim Öz‐Arslan et al, 2024, British J Pharmacology CrossRef